Empire Genomics is a growth stage business offering state of the art testing products and services for cancer disease management, that enable physicians to improve their diagnostic capabilities and tailor specific therapeutic treatments using patient DNA. Empire Genomics was created in 2006 from research at the prestigious Roswell Park Cancer Institute (www.roswellpark.org) as part of the Human Genome Project in Buffalo, New York under the leadership of University at Buffalo Professor Norma J. Nowak, Ph.D.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/02/14 | $1,000,000 |
Rand Capital Z80 Labs | undisclosed | |
| 05/20/16 | $1,750,000 | Follow-On |
BroadOak Capital Partners Rand Capital | undisclosed |
